Chagraoui, A.; Boulain, M.; Juvin, L.; Anouar, Y.; Barrière, G.; Deurwaerdère, P.D.
L-DOPA in Parkinson’s Disease: Looking at the “False” Neurotransmitters and Their Meaning. Int. J. Mol. Sci. 2020, 21, 294.
https://doi.org/10.3390/ijms21010294
AMA Style
Chagraoui A, Boulain M, Juvin L, Anouar Y, Barrière G, Deurwaerdère PD.
L-DOPA in Parkinson’s Disease: Looking at the “False” Neurotransmitters and Their Meaning. International Journal of Molecular Sciences. 2020; 21(1):294.
https://doi.org/10.3390/ijms21010294
Chicago/Turabian Style
Chagraoui, Abdeslam, Marie Boulain, Laurent Juvin, Youssef Anouar, Grégory Barrière, and Philippe De Deurwaerdère.
2020. "L-DOPA in Parkinson’s Disease: Looking at the “False” Neurotransmitters and Their Meaning" International Journal of Molecular Sciences 21, no. 1: 294.
https://doi.org/10.3390/ijms21010294
APA Style
Chagraoui, A., Boulain, M., Juvin, L., Anouar, Y., Barrière, G., & Deurwaerdère, P. D.
(2020). L-DOPA in Parkinson’s Disease: Looking at the “False” Neurotransmitters and Their Meaning. International Journal of Molecular Sciences, 21(1), 294.
https://doi.org/10.3390/ijms21010294